Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: The blood biomarkers study protocol of a randomized controlled trial (the ACT Trial)

Danni Li, Michelle M. Mielke, W. Robert Bell, Cavan Reilly, Lin Zhang, Feng Vankee Lin, Fang Yu

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: The blood biomarkers study protocol of a randomized controlled trial (the ACT Trial)'. Together they form a unique fingerprint.

Medicine & Life Sciences